首页 - 网校 - 万题库 - 美好明天 - 直播 - 团购 - 书城 - 学习通 - 导航 -
首页考试吧网校万题库直播美好明天团购书城模考论坛实用文档作文大全宝宝起名
2019中考
法律硕士
2019高考
MBA考试
2019考研
MPA考试
考研培训
中科院
在职研
专升本
自学考试 成人高考
四 六 级
GRE考试
攻硕英语
零起点日语
职称英语
口译笔译
申硕英语
零起点韩语
商务英语
日语等级
GMAT考试
公共英语
职称日语
新概念英语
专四专八
博思考试
零起点英语
托福考试
托业考试
零起点法语
雅思考试
成人英语三级
零起点德语
公 务 员
特岗教师
出版资格
物 流 师
法律职业资格
社会工作者
营养师
价格鉴证
心理咨询
跟 单 员
企业培训
驾 驶 员
报 关 员
单 证 员
管理咨询
营 销 师
报检员
秘书资格
法律顾问
普 通 话
保险从业
导游考试
网络编辑
电子商务
教师资格
教师招聘
人力资源管理师
国际货运代理人
一级建造师
安全工程师
土地估价师
岩土工程师
设备监理师
二级建造师
招标师考试
物业管理师
环保工程师
公路监理师
造价工程师
消防工程师
质量工程师
注册测绘师
公路造价师
造价员考试
电气工程师
城乡规划师
化工工程师
暖通工程师
咨询工程师
建筑师考试
结构工程师
材料员考试
注册给排水
监理工程师
房地产估价
注册计量师
安全评价师
二级消防工程
房地产经纪人
投资项目管理师
环境影响评价师
土地登记代理人
卫生资格 执业医师 执业药师 执业护士 初级护师 主管护师
基金从业 证券从业 银行从业 期货从业 理财规划 保荐代表人
会计从业资格
统计从业资格
注册税务师
经济师
精算师
统计师
会计职称
法律顾问
ACCA考试
初级会计职称
资产评估师
高级经济师
中级会计职称
注册会计师
CMA考试
审计师考试
国际内审师
美国注册会计师
高级会计师
等级考试
华为认证
水平考试
Java认证
职称计算机 微软认证 思科认证 Oracle认证 Linux认证
宝宝起名
缤纷校园
实用文档
入党申请
英语学习
思想汇报
作文大全
工作总结
求职招聘
职业技能
论文下载 直播课堂
热点搜索
学员登录 | 用户名
密码
新学员
老学员
您现在的位置: 考试吧 > 考研 > 考研模拟试题 > 考研英语模拟试题 > 正文

2019年考研英语阅读模拟题及答案详解(10)

来源:考试吧 2018-11-08 21:01:18 要考试,上考试吧! 考研万题库
2019年考研英语阅读模拟题及答案详解,更多2019考研英语模拟试题、考研英语备考资料等信息,请及时关注考试吧考研网或搜索公众微信“万题库考研”!

  查看汇总:2019年考研英语阅读模拟题及答案详解汇总

  At 18, Ashanthi DeSilva of suburban Cleveland is a living symbol of one of the great intellectual achievements of the 20th century. Born with an extremely rare and usually fatal disorder that left her without a functioning immune system (the “bubble-boy disease,” named after an earlier victim who was kept alive for years in a sterile plastic tent), she was treated beginning in 1990 with a revolutionary new therapy that sought to correct the defect at its very source, in the genes of her white blood cells. It worked. Although her last gene-therapy treatment was in 1992, she is completely healthy with normal immune function, according to one of the doctors who treated her, W. French Anderson of the University of Southern California. Researchers have long dreamed of treating diseases from hemophilia to cancer by replacing mutant genes with normal ones. And the dreaming may continue for decades more. “There will be a gene-based treatment for essentially every disease,” Anderson says, “within 50 years.”

  It's not entirely clear why medicine has been so slow to build on Anderson's early success. The National Institutes of Health budget office estimates it will spend $432 million on gene-therapy research in 2005, and there is no shortage of promising leads. The therapeutic genes are usually delivered through viruses that don't cause human disease. “The virus is sort of like a Trojan horse,” says Ronald Crystal of New York Presbyterian/Weill Cornell Medical College. “The cargo is the gene.”

  At the University of Pennsylvania's Abramson Cancer Center, immunologist Carl June recently treated HIV patients with a gene intended to help their cells resist the infection. At Cornell University, researchers are pursuing gene-based therapies for Parkinson's disease and a rare hereditary disorder that destroys children's brain cells. At Stanford University and the Children's Hospital of Philadelphia, researchers are trying to figure out how to help patients with hemophilia who today must inject themselves with expensive clotting drugs for life. Animal experiments have shown great promise.

  But somehow, things get lost in the translation from laboratory to patient. In human trials of the hemophilia treatment, patients show a response at first, but it fades over time. And the field has still not recovered from the setback it suffered in 1999, when Jesse Gelsinger, an 18-year-old with a rare metabolic disorder, died after receiving an experimental gene therapy at the University of Pennsylvania. Some experts worry that the field will be tarnished further if the next people to benefit are not patients but athletes seeking an edge. This summer, researchers at the Salk Institute in San Diego said they had created a “marathon mouse” by implanting a gene that enhances running ability; already, officials at the World Anti-Doping Agency are preparing to test athletes for signs of “gene doping.” But the principle is the same, whether you're trying to help a healthy runner run faster or allow a muscular-dystrophy patient to walk. “Everybody recognizes that gene therapy is a very good idea,” says Crystal. “And eventually it's going to work.”

  1. The case of Ashanthi Desilva is mentioned in the text to ____________.

  [A] show the promise of gene-therapy

  [B] give an example of modern treatment for fatal diseases

  [C] introduce the achievement of Anderson and his team

  [D] explain how gene-based treatment works

  2. Anderson‘s early success has ________________.

  [A] greatly speeded the development of medicine

  [B] brought no immediate progress in the research of gene-therapy

  [C] promised a cure to every disease

  [D] made him a national hero

  3. Which of the following is true according to the text?

  [A] Ashanthi needs to receive gene-therapy treatment constantly.

  [B] Despite the huge funding, gene researches have shown few promises.

  [C] Therapeutic genes are carried by harmless viruses.

  [D] Gene-doping is encouraged by world agencies to help athletes get better scores.

  4. The word “tarnish” (line 5, paragraph 4) most probably means ____________.

  [A] affect

  [B] warn

  [C] trouble

  [D] stain

  5. From the text we can see that the author seems ___________.

  [A] optimistic

  [B] pessimistic

  [C] troubled

  [D] uncertain

  答案:A B C D A

扫描/长按二维码关注可帮助考研通关
获取2019考研真题答案
获取2019考研大纲
获取2套仿真内部资料
获取历年考试真题试卷

考研万题库下载微信搜索"万题库考研"

  编辑推荐:

  2019考研英语阅读冲刺 掌握56条命题规律

  2019年考研英语作文11类模板助你高分

  2019年考研英语大纲5500词汇汇编(带下载)

  2019考研英语作文:80句高频短语及句式小结

  历年考研英语真题常考词汇大盘点

0
收藏该文章
0
收藏该文章
文章责编:wuxiaojuan825  
看了本文的网友还看了
文章搜索
万题库小程序
万题库小程序
·章节视频 ·章节练习
·免费真题 ·模考试题
微信扫码,立即获取!
扫码免费使用
版权声明:如果考研网所转载内容不慎侵犯了您的权益,请与我们联系800@exam8.com,我们将会及时处理。如转载本考研网内容,请注明出处。
Copyright © 2004- 考试吧考研网 出版物经营许可证新出发京批字第直170033号 
中国科学院研究生院权威支持(北京)
精选6套卷
8次直播课
大数据宝典
通关大法!
拉斯维加斯博彩